EDSA

EDSA

Edesa Biotech Inc

Edesa Biotech develops pharmaceutical products for inflammatory and immune-related diseases, focusing on monoclonal antibodies and topical treatments. Key candidates include EB05 for acute respiratory distress and EB01 for chronic allergic dermatitis.

โš•๏ธ Healthcare NASDAQ Listed 2015 $ USD
$1,000 invested 10 years ago โ†’$7today

Score Overview

1 Year
Scoreโ€”
Net Growth-8.77%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score3.2
Net Growth41.42%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-100.00%
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Score
Net Growth-55.51%
Net Trend30%
Net Income Consistency
Rev Growth-100.00%
Rev Trend10%
Revenue Consistency
All Time
Score
Net Growth-55.51%
Net Trend30%
Net Income Consistency
Rev Growth-100.00%
Rev Trend10%
Revenue Consistency

See the full market ranking โ†’

Edesa Biotech Inc fundamental performance

Between 2020 and 2025, revenue declined from $ 328.8K to $ 0.00 and net income went from -$ 6M to -$ 7M. Revenue increased in 0 of those 5 years; net income in 2.

Across Edesa Biotech Inc's full reported history, from 2016 to 2025, revenue declined from $ 1M to $ 0.00 and net income went from -$ 5M to -$ 7M. Revenue increased in 10% of the years measured; net income in 30%.

Edesa Biotech Inc currently holds a 5-year HDB Score of 3.2 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 5.30โ€”
1 Year2025-08-12
$ 2.17144.24%
5 Years2021-08-12
$ 31.85-83.36%
10 Years2016-08-12
$ 814.38-99.35%
All Time2015-11-05
$ 2.52K-99.79%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 7M$ 12M
2025$ 0.00-$ 7M$ 10M
2024$ 0.00-$ 6M$ 1M
2023$ 0.00-$ 8M$ 5M
2022$ 0.00-$ 17M$ 7M
2021$ 500.00-$ 13M$ 7M
2020$ 328.8K-$ 6M$ 7M
2019$ 410.87K-$ 2M$ 5M
2018$ 211.85K-$ 5M$ 10M
2017$ 228.29K-$ 5M$ 6M
2016$ 1M-$ 5M$ 11M

Explore beyond EDSA

You're looking at Edesa Biotech Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies